The Food and Drug Administration FDA announced on November 15 steps to strengthen its advisory committee processes in response to recent recommendations from the Institute of Medicine. The measures include proposed new guidance or procedures on advisoryThe Food and Drug Administration FDA announced on November 15 steps to strengthen its...
PUBLIC CITIZEN SAYS an analysis of FDAadvisory committee meetings between January 1997 and last July found the agency is making suhoptimum use of its advisory committee system. Writing in the December 23 issue of Lancet. Public Citizen said a declining minority of products up for approval face advisory committees,...
WOODCLIFF LAKE, N.J., May 7 /PRNewswire/ -- Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration FDAAdvisory Committee on Anesthetic and Life Support Drugs ALSDAC has voted 6 to 3 in favor with one abstention of...
GAITHERSBURG, Md., Feb. 9 /U.S. Newswire/ -- A citizens group called for the resignation of psychologist Louis A. Morris from the FDA's Advisory Committee on Drug Safety and Risk Management today. This came as the advisory committee met to discuss suddenGAITHERSBURG, Md., Feb. 9 /U.S. Newswire/ -- A citizens...
SAN CARLOS, Calif. -- Nektar Therapeutics (Nasdaq:NKTR) today reported that Pfizer Inc and the sanofi-aventis Group said that a U.S. Food and Drug Administration FDAadvisory committee panel has recommended the approval of ExuberaR (insulin rDNA origin powder for oral inhalation), an inhaleable, rapid-acting, dry powder insulin for the treatment...
ALAMEDA, Calif. -- Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that Jonathan H. Dinsmore Ph.D., Senior Vice President - Regulatory and Clinical, has been invited to present to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research Advisory Committee on Cellular, Tissue and Gene Therapies. Dr....
The U.S. FDA has announced new draft guidance that would implement a more stringent approach for considering potential conflicts of interest for its advisory committee members and for recommending eligibility for meeting participation. FDA is Current The U.S. FDA has announced new draft guidance that would...
TOWSON, Md. & WASHINGTON -- The Immune Deficiency Foundation, The Neuropathy Association and The Myositis Association have united to urge the U.S. Secretary of Health and Human Services Secretary Mike Leavitt to heed a recent recommendation to declare a public health emergency. The recommendation was approved unanimously on May 16...
DUBLIN, Ireland -- Elan Corporation, plc today announced it has agreed with the Irish Stock Exchange ISE, the Financial Services Authority in the United Kingdom and the New York Stock Exchange NYSE to suspend trading of its securities ADRs and ordinary shares during the scheduled U.S. Food and Drug Administration...
SUNNYVALE, Calif. -- Adeza (NASDAQ:ADZA) today announced that the Reproductive Health Drugs Advisory Committee to the U.S. Food and Drug Administration FDA recommended by a majority vote that the data presented by Adeza in its New Drug Application NDA for GestivaTM support efficacy in preventing preterm birth prior to 35...
Public disclosure of information packages provided to advisory committee members prior to a panel meeting could jeopardize trade secret and confidential/ commercial information, industry argues in recently released comments to the FDA. The comments are in response to an agency draft guidance entitled Disclosing Information Provided to Advisory Committees ...,...